Results per Page:
Patient stories, provider advice mark invasive lobular breast cancer awareness event
Fred Hutch experts discuss ILC’s hormonal risk factors, screening recommendations and new research
The body remembers: traces of breastfeeding linger in blood for decades
From the Sasamoto research group, Public Health Sciences Division
Every mile counts: Thousands unite for Fred Hutch Obliteride
More than 5,000 cyclists, walkers, runners and volunteers brought color, energy and connection to Fred Hutch Cancer Center’s annual bike ride and walk/run
Panorama actual de las tasas de supervivencia del cáncer de mama triple negativo metastásico
Del Laboratorio Hurvitz, División de Investigaciones Clínicas
Saying goodbye to a community partner and friend
Bridgette Hempstead, founder of Cierra Sisters and staunch health equity research advocate, remembered as a force for underserved patients
Turning grief into purpose
Lynn Lippert started fundraising for research at Fred Hutch as a patient and now her partner, Sal Jepson, continues to donate to honor all that she stood for
10 years in, HICOR’s efforts boost cancer care’s value
Fred Hutch’s Value in Cancer Care Initiative celebrates a decade of data and crucial collaborations between providers, payers and patients
New funding drives six breast cancer studies
Scientists from Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium receive $1.7M in grants from Breast Cancer Research Foundation
Fred Hutch Breast Sexual Health Clinic supports patients’ intimacy needs
No matter what stage of treatment, providers create safe space
From overlooked to understood, a Black woman’s case gets the attention it deserves
Partnership is key to making patients of color feel respected
Mammogram vans remove barriers that people face accessing breast cancer screening
Fred Hutch focuses on improving screening in under-resourced communities
A promising antibody-drug conjugate for treating brain metastases in breast cancer patients
From the Hurvitz Lab, Clinical Research Division
Young breast cancer patient’s self-exam and self-advocacy leads to cancer diagnosis
Gillian McDonald chooses Fred Hutch for care, including participating in clinical trials that led to being selected for proton therapy
Sacituzumab govitecán para el cáncer de mama metastásico triple negativo
De la Dra. Sara Hurvitz, División de Investigación Clínica
Cost-effective device trains immune cells to kill tumor cells
From the Matthias Stephan Lab, Translational Science & Therapeutics Division
Sacituzumab govitecan for metastatic triple-negative breast cancer
From Dr. Sara Hurvitz, Clinical Research Division
Breast cancer screening guidelines change — again
U.S. Preventive Services Task Force recommends mammograms every other year for those at average risk, starting at age 40
Dedicated supporters at the Heart of the Hutch
Using creativity and passion to support Fred Hutch research in good times and bad